title: EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma.
abstract: In 1982 there were four reports of cisplatin-induced remissions of invasive thymoma. These observations led the Eastern Cooperative Oncology Group (ECOG) to conduct a Phase II trial of cisplatin (50 mg/m2 intravenously every 3 weeks). During a 4-year period 24 patients were entered on this trial; 3 were excluded because review of histologic material failed to confirm the presence of thymoma. The characteristics of the remaining 21 patients were as follows: median age, 51; males/females, 11/10; ECOG performance status, 0-1/2-3, 16/5; previous treatment with chemotherapy, 3; previous surgery, 20; previous radiation, 15; weight loss, < 5%/ > or = 5%: 17/4. One patient was eliminated from response analysis because of failure to return for follow-up tumor measurements. The following responses were observed in the remaining 20 patients. Partial remission, 2 (10%); stable disease, 8 (40%); and progression, 10 (50%). The median survival was 76 weeks, and the 2-year survival rate was 39%. Four patients experienced severe nausea and vomiting, but life-threatening and lethal toxicities were not observed. Cisplatin given at this dose was relatively ineffective in producing tumor regression in recurrent or metastatic thymoma.
authors.affiliation: Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
authors.forename: P D
authors.initials: PD
authors.lastname: Bonomi
authors.forename: D
authors.initials: D
authors.lastname: Finkelstein
authors.forename: S
authors.initials: S
authors.lastname: Aisner
authors.forename: D
authors.initials: D
authors.lastname: Ettinger
mesh_terms: D000368:Aged; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D012074:Remission Induction; D016019:Survival Analysis; D013945:Thymoma / Q000188:drug therapy* / Q000556:secondary*; D013953:Thymus Neoplasms / Q000188:drug therapy*
chemical_list: D002945:Cisplatin